Call for Proposals

About CTAD

The Center for Therapeutic Antibody Development (CTAD) is looking for promising targets for monoclonal antibodies (mAbs) production. Funding is available for investigators that have identified targets with potential therapeutic or diagnostic value. Investigators with targets that are scientifically novel and at an early stage of investigation are encouraged to apply. CTAD will synthesize targets proteins for immunization and screening, generate panels of monoclonal antibodies and collaborate with investigators to identify and characterize antibodies with the greatest commercial potential.


Accepting application to be announced.

Contact Us

Center for Therapeutic Antibody Development (CTAD)
Send e-mail
Tel: 212-241-7963
Fax: 212-241-3523

One Gustave L. Levy Place
Annenberg Building, 17th Floor
New York, NY 10029